<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Hum. Neurosci.</journal-id>
<journal-title>Frontiers in Human Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Hum. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5161</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnhum.2023.1126553</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Human Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Profiles of cognitive impairment in chronic heart failure&#x02014;A cluster analytic approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>G&#x000F6;pfert</surname> <given-names>Dennis</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1974763/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name><surname>Traub</surname> <given-names>Jan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2137655/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sell</surname> <given-names>Roxane</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Homola</surname> <given-names>Gy&#x000F6;rgy A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/680994/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Vogt</surname> <given-names>Marius</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pham</surname> <given-names>Mirko</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1329441/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Frantz</surname> <given-names>Stefan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>St&#x000F6;rk</surname> <given-names>Stefan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1660883/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Stoll</surname> <given-names>Guido</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/223354/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Frey</surname> <given-names>Anna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/173272/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Comprehensive Heart Failure Center, University Hospital W&#x000FC;rzburg</institution>, <addr-line>W&#x000FC;rzburg</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Medicine I, University Hospital W&#x000FC;rzburg</institution>, <addr-line>W&#x000FC;rzburg</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Psychiatry, Psychosomatics, Psychotherapy, University Hospital W&#x000FC;rzburg</institution>, <addr-line>W&#x000FC;rzburg</addr-line>, <country>Germany</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Neuroradiology, University Hospital W&#x000FC;rzburg</institution>, <addr-line>W&#x000FC;rzburg</addr-line>, <country>Germany</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Neurology, University Hospital W&#x000FC;rzburg</institution>, <addr-line>W&#x000FC;rzburg</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Wilburn Reddick, St. Jude Children&#x00027;s Research Hospital, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: James Stefaniak, University of Cambridge, United Kingdom; Lisa C. Bratzke, University of Wisconsin-Madison, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Jan Traub <email>Traub_J1&#x00040;ukw.de</email></corresp>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn></author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>04</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1126553</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2023 G&#x000F6;pfert, Traub, Sell, Homola, Vogt, Pham, Frantz, St&#x000F6;rk, Stoll and Frey.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>G&#x000F6;pfert, Traub, Sell, Homola, Vogt, Pham, Frantz, St&#x000F6;rk, Stoll and Frey</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<abstract>
<sec>
<title>Background</title>
<p>Cognitive impairment is a major comorbidity in patients with chronic heart failure (HF) with a wide range of phenotypes. In this study, we aimed to identify and compare different clusters of cognitive deficits.</p>
</sec>
<sec>
<title>Methods</title>
<p>The prospective cohort study &#x0201C;Cognition.Matters-HF&#x0201D; recruited 147 chronic HF patients (aged 64.5 &#x000B1; 10.8 years; 16.2% female) of any etiology. All patients underwent extensive neuropsychological testing. We performed a hierarchical cluster analysis of the cognitive domains, such as intensity of attention, visual/verbal memory, and executive function. Generated clusters were compared exploratively with respect to the results of cardiological, neurological, and neuroradiological examinations without correction for multiple testing.</p>
</sec>
<sec>
<title>Results</title>
<p>Dendrogram and the scree plot suggested three distinct cognitive profiles: In the first cluster, 42 patients (28.6%) performed without any deficits in all domains. Exclusively, the intensity of attention deficits was seen in the second cluster, including 55 patients (37.4%). A third cluster with 50 patients (34.0%) was characterized by deficits in all cognitive domains. Age (<italic>p</italic> = 0.163) and typical clinical markers of chronic HF, such as ejection fraction (<italic>p</italic> = 0.222), 6-min walking test distance (<italic>p</italic> = 0.138), NT-proBNP (<italic>p</italic> = 0.364), and New York Heart Association class (<italic>p</italic> = 0.868) did not differ between clusters. However, we observed that women (<italic>p</italic> = 0.012) and patients with previous cardiac valve surgery (<italic>p</italic> = 0.005) prevailed in the &#x0201C;global deficits&#x0201D; cluster and the &#x0201C;no deficits&#x0201D; group had a lower prevalence of underlying arterial hypertension (<italic>p</italic> = 0.029). Total brain volume (<italic>p</italic> = 0.017) was smaller in the global deficit cluster, and serum levels of glial fibrillary acidic protein were increased (<italic>p</italic> = 0.048).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Apart from cognitively healthy and globally impaired HF patients, we identified a group with deficits only in the intensity of attention. Women and patients with previous cardiac valve surgery are at risk for global cognitive impairment when suffering HF and could benefit from special multimodal treatment addressing the psychosocial condition.</p>
</sec></abstract>
<kwd-group>
<kwd>chronic heart failure</kwd>
<kwd>cluster analysis</kwd>
<kwd>cognitive impairment</kwd>
<kwd>intensity of attention</kwd>
<kwd>glial fibrillary acidic protein</kwd>
</kwd-group>
<contract-num rid="cn001">391580509</contract-num>
<contract-num rid="cn001">413657723</contract-num>
<contract-num rid="cn001">453989101</contract-num>
<contract-num rid="cn002">01EO1004</contract-num>
<contract-num rid="cn002">01ES01901</contract-num>
<contract-num rid="cn002">01ES01902</contract-num>
<contract-num rid="cn002">01ES0816</contract-num>
<contract-sponsor id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></contract-sponsor>
<contract-sponsor id="cn002">Bundesministerium f&#x000FC;r Bildung und Forschung<named-content content-type="fundref-id">10.13039/501100002347</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="36"/>
<page-count count="9"/>
<word-count count="6644"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Imaging and Stimulation</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1. Introduction</title>
<p>Due to the aging population and improved survival after myocardial infarction, the prevalence of chronic heart failure (HF) is constantly increasing (Ponikowski et al., <xref ref-type="bibr" rid="B20">2016</xref>). Envisaged holistic care includes the identification and targeted treatment of secondary comorbidities (Ponikowski et al., <xref ref-type="bibr" rid="B20">2016</xref>). Multiple cross-sectional studies described relevant cognitive impairment (CI) in almost every second HF patient, which relates to the adverse outcomes and increased healthcare costs (Sauve et al., <xref ref-type="bibr" rid="B26">2009</xref>; Almeida et al., <xref ref-type="bibr" rid="B1">2012</xref>; Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). While the etiology of CI in HF is complex and subject to current research, CI mostly affects the domains of the intensity of attention, memory, and executive functions (Wolfe et al., <xref ref-type="bibr" rid="B33">2006</xref>; Vogels et al., <xref ref-type="bibr" rid="B31">2007</xref>; Okonkwo et al., <xref ref-type="bibr" rid="B19">2010</xref>; Pressler et al., <xref ref-type="bibr" rid="B22">2011</xref>). It has been shown that the extent of these deficits correlates with the severity of chronic HF and varies in the degree of stability, ranging from reversible CI to chronic courses (Dardiotis et al., <xref ref-type="bibr" rid="B9">2012</xref>). Because of these complexities, neuropsychological assessment of subtle, subclinical cognitive changes is of great importance. From a therapeutic perspective, early intervention could help to halt CI deterioration and the development of dementia. However, little is known about the individual cognitive profiles and their clinical or prognostic importance in HF patients (Pullicino and Hart, <xref ref-type="bibr" rid="B23">2001</xref>).</p>
<p>Therefore, this <italic>post hoc</italic> analysis aims to characterize distinct patterns of CI, identify their clinical characteristics, and evaluate their prognostic impact. We performed hierarchical clustering of chronic HF patients according to their performance in neuropsychological testing and analyzed clinical, laboratory, and apparative data of 147 patients within the comprehensive Cognition.Matters-HF study.</p>
</sec>
<sec id="s2">
<title>2. Materials and methods</title>
<sec>
<title>2.1. Study design and examinations</title>
<p>The interdisciplinary, investigator-initiated, single-centered, prospective cohort study &#x0201C;Cognition.Matters-HF&#x0201D; was approved by the local Ethics Committee (study registration number 245/10) and complies with the Declaration of Helsinki, as previously published (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). Patients with stable chronic systolic or diastolic HF without major psychiatric or neurologic disorders were eligible (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>). All patients underwent an extensive interdisciplinary workup according to a prespecified protocol. Examinations included cardiovascular and neurological clinical examination, neuropsychological test battery, electrocardiogram, echocardiography, 6-min walk testing, and brain magnetic resonance imaging (MRI). We measured routine blood parameters and the neurodegenerative serum biomarkers neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and phosphorylated Tau protein (pTau) according to a prespecified protocol from venous blood (Traub et al., <xref ref-type="bibr" rid="B28">2022</xref>).</p>
</sec>
<sec>
<title>2.2. Neuropsychological testing</title>
<p>Patients underwent an extensive neuropsychological test battery (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 2</xref>) with a duration of 1 h between 9 and 11 a.m. to guard against circadian power fluctuation. The test outputs are given as standardized <italic>t</italic>-values to account for the modifying effect of age, sex, and educational level. Test Battery of Attentional Performance quantified intensity and selectivity of attention. The intensity of attention refers to the focus on and maintenance of the given tasks. For visual/verbal memory and working memory, Visual and Verbal Memory Test, Digit Span Forward, and Block Tapping Span Forward tests were applied. Visual/verbal fluency was analyzed using Regensburger Word Fluency Test and HAMASCH-5-Point-Test (<xref ref-type="table" rid="T1">Table 1</xref>). The reliability of tests ranged between 0.60 and 0.99 (Schellig and Sch&#x000E4;chtele, <xref ref-type="bibr" rid="B27">2009</xref>). Executive function comprised the domains selectivity of attention, working memory, and visual/verbal fluency. The test battery was compiled by a trained neuropsychologist in an elaborate process. To reduce any form of bias, the tasks were not only spoken to the patients but also played to them in a standardized way.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Distribution of neuropsychological tests and assessed variables according to subdivision into the three cognitive areas intensity of attention, memory, and executive functions.</p></caption> 
<table frame="box" rules="all">
<thead>
<tr style="background-color:&#x00023;919498;color:&#x00023;ffffff">
<th valign="top" align="left"><bold>Test</bold></th>
<th valign="top" align="left"><bold>Cognitive domain/specification</bold></th>
<th valign="top" align="left"><bold><italic>T</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#e0e1e3">
<td/>
<td valign="top" align="left"><bold>Intensity of attention</bold></td>
<td/>
</tr> <tr>
<td valign="top" align="left">TAP Alertness</td>
<td valign="top" align="left">Alertness, reaction times</td>
<td valign="top" align="left">Median of reaction times with and without previous acoustic signal</td>
</tr> <tr style="background-color:#e0e1e3">
<td/>
<td valign="top" align="left"><bold>Memory</bold></td>
<td/>
</tr> <tr>
<td valign="top" align="left">VVM 2 map</td>
<td valign="top" align="left">Short- and medium-term visual memory</td>
<td valign="top" align="left">Number of correct crosses</td>
</tr> <tr>
<td valign="top" align="left">VVM 2 text</td>
<td valign="top" align="left">Short- and medium-term verbal memory</td>
<td valign="top" align="left">Number of correct responses</td>
</tr> <tr style="background-color:#e0e1e3">
<td/>
<td valign="top" align="left"><bold>Executive functions</bold></td>
<td/>
</tr> <tr>
<td valign="top" align="left">TAP GoNoGo</td>
<td valign="top" align="left">Selectivity of attention (focusing, response inhibition)</td>
<td valign="top" align="left">Number of errors</td>
</tr> <tr>
<td valign="top" align="left">TAP Divided Attention</td>
<td valign="top" align="left">Selectivity of attention (dividing)</td>
<td valign="top" align="left">Number of errors</td>
</tr> <tr>
<td valign="top" align="left">WMS-R digit span</td>
<td valign="top" align="left">Verbal working memory</td>
<td valign="top" align="left">Number of correctly remembered series</td>
</tr> <tr>
<td valign="top" align="left">WMS-R block tapping span</td>
<td valign="top" align="left">Visual working memory</td>
<td valign="top" align="left">Number of correctly touched series</td>
</tr> <tr>
<td valign="top" align="left">RWT lexically change of categories</td>
<td valign="top" align="left">Verbal fluency (spontaneous cognitive flexibility, shifting)</td>
<td valign="top" align="left">Number of correct words</td>
</tr> <tr>
<td valign="top" align="left">H5PT</td>
<td valign="top" align="left">Visual fluency (spontaneous cognitive flexibility)</td>
<td valign="top" align="left">Number of correct patterns</td>
</tr></tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>2.3. Generation of clusters</title>
<p>We performed hierarchical clustering according to cognitive function using Ward&#x00027;s method and squared Euclidean distance as a similarity measure of the three variables intensity of attention, memory, and executive functions. For each cluster number, the sum of squares was calculated by the statistical program. The curve of the sum of squares was plotted according to the number of clusters (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The location of a bend (knee) in the plot is generally considered an indicator of the appropriate number of clusters (Hunt and Jorgensen, <xref ref-type="bibr" rid="B14">2011</xref>; Prasanna and Vijaya, <xref ref-type="bibr" rid="B21">2022</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Visualization of cognitive clustering. <bold>(A)</bold> Dendrogram for hierarchical representation of clusters. Each leaf represents an individual observation. Leaves are spaced evenly along the vertical axis. The horizontal axis indicates a distance or dissimilarity measure. The height of a node represents the distance between the two clusters. The graph is used to visualize how clusters are formed. The number of clusters that seemed to have an optimal dissimilarity measure within each cluster was set at three. <bold>(B)</bold> Scree plot derived from hierarchical cluster analysis. The <italic>y</italic>-axis represents the degree of homogeneity within the cluster, while the <italic>x</italic>-axis shows the number of clusters. The optimal number was set at the bend of the curve, which also was at three clusters confirming visual determination by our dendrogram. <bold>(C)</bold> Three-dimensional visualization and line diagram of cognitive clusters as generated by subsequent k-means cluster analysis. Each point represents an HF patient. Lines represent the central trend of the cases in terms of their cognition. <bold>(D)</bold> T-scores of the cognitive domains are given. Dots represent a single patient; centroid projection was applied. Whiskers display mean and 95% confidence intervals.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnhum-17-1126553-g0001.tif"/>
</fig>
</sec>
<sec>
<title>2.4. Cerebral MRI and processing</title>
<p>Brain MRI was performed on a 3 Tesla scanner (Siemens MAGNETOM Trio, Erlangen, Germany) using a 12-channel head coil. Sequences included T1W FLASH, T1W 3D TFL, T2W FLAIR, T2W TSE, DWI, localizers, SV spectroscopy, and ASL perfusion (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 3</xref>). Cerebral atrophy was rated visually on a scale from 1 to 8, medial temporal lobe atrophy by Scheltens&#x00027;s score from 0 (normal) to 4 (severe atrophy), and white matter hyperintensities (WMH) using Fazekas score, ranging from 0 to 3. Mean Scheltens&#x00027;s score &#x02265;1.5 in patients younger than 75 years and &#x02265;2 in patients older than 75 years was considered pathological (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). MRI analysis was performed according to the study protocols of ASPS and ASPS-Fam. The MRI recordings were made semi-quantitatively. Images were read and documented by an expert neuroradiological doctor. The findings were formally approved by a second senior neuroradiologist. Afterward, the available imaging data were compared with the available imaging data of healthy controls. Cerebral scores were rated visually. The investigator had no access to further data of the patients. There was no further calculation for inter-rater reliability (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>).</p>
</sec>
<sec>
<title>2.5. Statistical analysis</title>
<p>Variables are depicted as median (interquartile range) for metric and interval scaled data or count (percentage) for ordinal and nominal data. ANOVA test or <italic>t</italic>-test was used. In the absence of a normal distribution or violation of other assumptions, non-parametric procedures such as the Kruskal&#x02013;Wallis or the Mann&#x02013;Whitney <italic>U</italic>-test were used. If Levene&#x00027;s test was significant, indicating missing variance homogeneity between groups, Welch&#x00027;s <italic>t</italic>-test was used. <italic>Post hoc</italic> analysis included Scheff&#x000E9;&#x00027;s test for variables with homogeneous variance and Dunnett&#x00027;s T3 test for those without. For nominally scaled variables, the chi-squared test or Fisher&#x00027;s exact test was used, the latter was taken into account when sample sizes within cells were below five. The statistical software package SPSS, version 27, was used.</p>
</sec>
</sec>
<sec id="s3">
<title>3. Results</title>
<sec>
<title>3.1. Clinical characteristics of the study cohort</title>
<p>The comprehensive baseline characteristics of 148 included chronic HF patients within the Cognition.Matters-HF study have been previously described in detail (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>) and are provided in <xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 4</xref>. The complete neuropsychological examination was available in 147 participants, aged 63.9 &#x000B1; 10.8 years; 23 patients were female (15.6%). The severity of HF symptoms was mild in the majority of patients, with 77% in NYHA functional class I or II. The most common reason for HF was coronary artery disease (65%). The mean 6-min walking distance was 392 &#x000B1; 99 m, while the mean left ventricular ejection fraction was 42.5 &#x000B1; 8.1%. The prevalence of deficits in at least one cognitive domain was 59.9%.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Patient characteristics according to cognitive clusters.</p></caption> 
<table frame="box" rules="all">
<thead>
<tr style="background-color:&#x00023;919498;color:&#x00023;ffffff">
<th valign="top" align="left"><bold>Parameter</bold></th>
<th valign="top" align="left"><bold>All patients (<italic>n</italic> = 147)</bold></th>
<th valign="top" align="left"><bold>No deficits (1) (<italic>n</italic> = 42)</bold></th>
<th valign="top" align="left"><bold>Attention deficits (2) (<italic>n</italic> = 55)</bold></th>
<th valign="top" align="left"><bold>Global deficits (3) (<italic>n</italic> = 50)</bold></th>
<th valign="top" align="left"><bold><italic>P</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Cognitive domains</bold></td>
</tr> <tr>
<td valign="top" align="left">Intensity of attention</td>
<td valign="top" align="left">41.5 (36.5&#x02013;47.0)</td>
<td valign="top" align="left">49.3 (46.4&#x02013;52.5)</td>
<td valign="top" align="left">38.5 (34.5&#x02013;41.5)</td>
<td valign="top" align="left">39.5 (35.9&#x02013;44.0)</td>
<td valign="top" align="left"><bold>0.001</bold><sup><bold>1&#x0003E;2, 1&#x0003E;3</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Memory (visual/verbal)</td>
<td valign="top" align="left">45.3 (39.5&#x02013;51.5)</td>
<td valign="top" align="left">46.1 (43.7&#x02013;51.1)</td>
<td valign="top" align="left">51.5 (46.0&#x02013;54.3)</td>
<td valign="top" align="left">38.8 (34.3&#x02013;39.8)</td>
<td valign="top" align="left"><bold>0.001</bold><sup><bold>1&#x0003E;3, 2&#x0003E;3</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Executive functions</td>
<td valign="top" align="left">44.8 (41.7&#x02013;49.7)</td>
<td valign="top" align="left">46.7 (42.8&#x02013;52.2)</td>
<td valign="top" align="left">46.8 (44.5&#x02013;50.3)</td>
<td valign="top" align="left">41.1 (38.8&#x02013;44.1)</td>
<td valign="top" align="left"><bold>0.001</bold><sup><bold>1&#x0003E;3, 2&#x0003E;3</bold></sup></td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Sociodemographic</bold></td>
</tr> <tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="left">65 (56&#x02013;72)</td>
<td valign="top" align="left">66 (54&#x02013;75)</td>
<td valign="top" align="left">63 (54&#x02013;70)</td>
<td valign="top" align="left">68 (58&#x02013;74)</td>
<td valign="top" align="left">0.163</td>
</tr> <tr>
<td valign="top" align="left">Female sex</td>
<td valign="top" align="left">23 (15)</td>
<td valign="top" align="left">4 (10)</td>
<td valign="top" align="left">5 (9)</td>
<td valign="top" align="left">14 (28)</td>
<td valign="top" align="left"><bold>0.012</bold><sup><bold>3&#x0003E;2</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Body mass index (kg/m<sup>2</sup>)</td>
<td valign="top" align="left">28 (26&#x02013;32)</td>
<td valign="top" align="left">28 (25&#x02013;31)</td>
<td valign="top" align="left">29 (26&#x02013;33)</td>
<td valign="top" align="left">28 (26&#x02013;31)</td>
<td valign="top" align="left">0.603</td>
</tr> <tr>
<td valign="top" align="left">Education level (university entrance qualification)</td>
<td valign="top" align="left">29 (20)</td>
<td valign="top" align="left">8 (19)</td>
<td valign="top" align="left">13 (24)</td>
<td valign="top" align="left">8 (16)</td>
<td valign="top" align="left">0.491</td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Cardiovascular</bold></td>
</tr> <tr>
<td valign="top" align="left">Heart rate (bpm)</td>
<td valign="top" align="left">63 (58&#x02013;70)</td>
<td valign="top" align="left">60 (57&#x02013;71)</td>
<td valign="top" align="left">62 (57&#x02013;67)</td>
<td valign="top" align="left">68 (59&#x02013;75)</td>
<td valign="top" align="left"><bold>0.035</bold><sup><bold>3&#x0003E;2</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Systolic blood pressure (mmHg)</td>
<td valign="top" align="left">136 (125&#x02013;151)</td>
<td valign="top" align="left">135 (120&#x02013;151)</td>
<td valign="top" align="left">138 (125&#x02013;153)</td>
<td valign="top" align="left">138 (126&#x02013;149)</td>
<td valign="top" align="left">0.775</td>
</tr> <tr>
<td valign="top" align="left">Diastolic blood pressure (mmHg)</td>
<td valign="top" align="left">80 (75&#x02013;89)</td>
<td valign="top" align="left">80 (75&#x02013;85)</td>
<td valign="top" align="left">84 (73&#x02013;90)</td>
<td valign="top" align="left">80 (75&#x02013;89)</td>
<td valign="top" align="left">0.677</td>
</tr> <tr>
<td valign="top" align="left">NYHA class I</td>
<td valign="top" align="left">41 (28)</td>
<td valign="top" align="left">13 (31)</td>
<td valign="top" align="left">13 (24)</td>
<td valign="top" align="left">15 (30)</td>
<td valign="top" align="left">0.868</td>
</tr> <tr>
<td valign="top" align="left">NYHA class II</td>
<td valign="top" align="left">87 (59)</td>
<td valign="top" align="left">25 (60)</td>
<td valign="top" align="left">34 (62)</td>
<td valign="top" align="left">28 (56)</td>
<td valign="top" align="left">0.868</td>
</tr> <tr>
<td valign="top" align="left">NYHA class III</td>
<td valign="top" align="left">19 (13)</td>
<td valign="top" align="left">4 (10)</td>
<td valign="top" align="left">8 (15)</td>
<td valign="top" align="left">7 (14)</td>
<td valign="top" align="left">0.868</td>
</tr> <tr>
<td valign="top" align="left">Length of HF diagnosis (years)</td>
<td valign="top" align="left">4.0 (1.0&#x02013;10.0)</td>
<td valign="top" align="left">6.0 (1.8&#x02013;11.3)</td>
<td valign="top" align="left">4.0 (1.0&#x02013;9.0)</td>
<td valign="top" align="left">4.0 (1.0&#x02013;10.3)</td>
<td valign="top" align="left">0.487</td>
</tr> <tr>
<td valign="top" align="left">6-min walking test distance (m)</td>
<td valign="top" align="left">400 (340&#x02013;460)</td>
<td valign="top" align="left">420 (360&#x02013;480)</td>
<td valign="top" align="left">420 (350&#x02013;460)</td>
<td valign="top" align="left">380 (305&#x02013;440)</td>
<td valign="top" align="left">0.138</td>
</tr> <tr>
<td valign="top" align="left">Left ventricular ejection fraction (%)</td>
<td valign="top" align="left">44 (38&#x02013;48)</td>
<td valign="top" align="left">42 (35&#x02013;47)</td>
<td valign="top" align="left">45 (41&#x02013;48)</td>
<td valign="top" align="left">44 (36&#x02013;48)</td>
<td valign="top" align="left">0.222</td>
</tr> <tr>
<td valign="top" align="left">NT-proBNP (pg/ml)</td>
<td valign="top" align="left">672 (237&#x02013;1,677)</td>
<td valign="top" align="left">680 (254&#x02013;1,907)</td>
<td valign="top" align="left">435 (154&#x02013;1,036)</td>
<td valign="top" align="left">879 (412&#x02013;1,853)</td>
<td valign="top" align="left">0.364</td>
</tr> <tr>
<td valign="top" align="left">Hemoglobin A1c (%)</td>
<td valign="top" align="left">6.0 (5.5&#x02013;6.6)</td>
<td valign="top" align="left">6.0 (5.5&#x02013;6.5)</td>
<td valign="top" align="left">6.0 (5.5&#x02013;6.6)</td>
<td valign="top" align="left">5.9 (5.5&#x02013;6.6)</td>
<td valign="top" align="left">0.133</td>
</tr> <tr>
<td valign="top" align="left">Low-density lipoprotein (md/dl)</td>
<td valign="top" align="left">98.5 (78.0&#x02013;123.3)</td>
<td valign="top" align="left">100.5 (77.8&#x02013;123.5)</td>
<td valign="top" align="left">97.5 (74.3&#x02013;119.8)</td>
<td valign="top" align="left">100.0 (82.0&#x02013;134.0)</td>
<td valign="top" align="left">0.168</td>
</tr> <tr>
<td valign="top" align="left">Ischemic heart failure</td>
<td valign="top" align="left">95 (64)</td>
<td valign="top" align="left">26 (61)</td>
<td valign="top" align="left">39 (70)</td>
<td valign="top" align="left">30 (60)</td>
<td valign="top" align="left">0.460</td>
</tr> <tr>
<td valign="top" align="left">Guideline-based heart failure therapy</td>
<td valign="top" align="left">124 (84)</td>
<td valign="top" align="left">36 (86)</td>
<td valign="top" align="left">48 (87)</td>
<td valign="top" align="left">40 (80)</td>
<td valign="top" align="left">0.568</td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Risk factors</bold></td>
</tr> <tr>
<td valign="top" align="left">Diabetes mellitus type II</td>
<td valign="top" align="left">43 (29)</td>
<td valign="top" align="left">11 (26)</td>
<td valign="top" align="left">19 (35)</td>
<td valign="top" align="left">13 (26)</td>
<td valign="top" align="left">0.551</td>
</tr> <tr>
<td valign="top" align="left">Arterial hypertension</td>
<td valign="top" align="left">118 (80)</td>
<td valign="top" align="left">28 (67)</td>
<td valign="top" align="left">48 (87)</td>
<td valign="top" align="left">42 (84)</td>
<td valign="top" align="left"><bold>0.029</bold><sup><bold>2&#x0003E;1</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Hyperlipidemia</td>
<td valign="top" align="left">106 (72)</td>
<td valign="top" align="left">33 (79)</td>
<td valign="top" align="left">43 (78)</td>
<td valign="top" align="left">30 (60)</td>
<td valign="top" align="left">0.063</td>
</tr> <tr>
<td valign="top" align="left">(Former) smoking</td>
<td valign="top" align="left">88 (60)</td>
<td valign="top" align="left">31 (74)</td>
<td valign="top" align="left">33 (60)</td>
<td valign="top" align="left">24 (48)</td>
<td valign="top" align="left"><bold>0.042</bold><sup><bold>1&#x0003E;3</bold></sup></td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Comorbidities</bold></td>
</tr> <tr>
<td valign="top" align="left">Coronary artery disease</td>
<td valign="top" align="left">99 (67)</td>
<td valign="top" align="left">29 (69)</td>
<td valign="top" align="left">39 (71)</td>
<td valign="top" align="left">31 (62)</td>
<td valign="top" align="left">0.600</td>
</tr> <tr>
<td valign="top" align="left">History of myocardial infarction</td>
<td valign="top" align="left">79 (54)</td>
<td valign="top" align="left">24 (57)</td>
<td valign="top" align="left">34 (62)</td>
<td valign="top" align="left">21 (42)</td>
<td valign="top" align="left">0.110</td>
</tr> <tr>
<td valign="top" align="left">Atrial fibrillation</td>
<td valign="top" align="left">34 (23)</td>
<td valign="top" align="left">14 (33)</td>
<td valign="top" align="left">7 (13)</td>
<td valign="top" align="left">13 (26)</td>
<td valign="top" align="left"><bold>0.049</bold><sup><bold>1&#x0003E;2</bold></sup></td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Previous interventions</bold></td>
</tr> <tr>
<td valign="top" align="left">Coronary revascularization</td>
<td valign="top" align="left">70 (48)</td>
<td valign="top" align="left">21 (50)</td>
<td valign="top" align="left">30 (55)</td>
<td valign="top" align="left">19 (38)</td>
<td valign="top" align="left">0.288</td>
</tr> <tr>
<td valign="top" align="left">Valvular operations</td>
<td valign="top" align="left">10 (7)</td>
<td valign="top" align="left">0 (0)</td>
<td valign="top" align="left">2 (4)</td>
<td valign="top" align="left">8 (16)</td>
<td valign="top" align="left"><bold>0.005</bold><sup><bold>3&#x0003E;1</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Reanimation/defibrillation</td>
<td valign="top" align="left">8 (5)</td>
<td valign="top" align="left">1 (2)</td>
<td valign="top" align="left">5 (9)</td>
<td valign="top" align="left">2 (4)</td>
<td valign="top" align="left">0.386</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>Count (percentage) and median (interquartile range) are shown. Significant differences in <italic>post hoc</italic> analyses are indicated by greater than (&#x0003E;) and less than (&#x0003C;) sign. HF, heart failure; NYHA, New York Heart Association. Bold numbers indicate values equal to or below a significance level of <italic>p</italic> = 0.05.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>3.2. Generation and description of cognitive clusters</title>
<p>The cluster analysis is based on composite T-scores of the three cognitive domains intensity of attention, memory, and executive functions. We performed hierarchical agglomerative cluster analysis using Ward&#x00027;s method and the squared Euclidean distance. Examining the dendrogram and the scree plot (<xref ref-type="fig" rid="F1">Figure 1</xref>) suggested a three-cluster solution. Ward&#x00027;s method clustering rendered a first group, which comprised 42 patients (28.6%), showed nearly normal performance in all three domains of cognition and was therefore labeled &#x0201C;no deficits&#x0201D; (ND). A total of 55 HF patients (37.4%) in a second &#x0201C;attention deficit&#x0201D; (AD) cluster showed only selective deficits in the domain intensity of attention. The third cluster included 50 patients (34.0%) and was characterized by deficits in all domains (&#x0201C;global deficits&#x0201D;; GD). As a proof of concept, we found significant differences in all three cognitive domains between all clusters (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 4</xref>). To investigate the particular impairment of intensity of attention in the second cluster, we also analyzed how the cognitive domains related to each other (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref>). While the T-scores of visual/verbal memory correlated significantly positively with executive functions, the intensity of attention did not correlate to any of the other two domains. We also compared the total cohort to the norm of a T-score of 50 for all cognitive domains and found a significant difference of <italic>p</italic> &#x0003C; 0.001.</p>
</sec>
<sec>
<title>3.3. Clinical comparison of clusters</title>
<p>Next, we aimed to detect clinical differences between generated cognitive clusters in an exploratory approach. As depicted in <xref ref-type="table" rid="T2">Table 2</xref>, chronic HF parameters such as 6-min walking distance, New York Heart Association Class, NT-proBNP, and left ventricular ejection fraction did not differ between clusters. While age also did not diverge between clusters, the proportion of women in the clusters differed significantly with the highest percentages in the GD cluster. This group also had a higher proportion of valve surgeries and tended to have lower hemoglobin levels (<italic>p</italic> = 0.035). Similarly, lower mean corpuscular hemoglobin concentration (<italic>p</italic> = 0.043) and higher heart rate (<italic>p</italic> = 0.035) could be differentiated. Atrial fibrillation was lowest in the &#x0201C;attention deficits&#x0201D; cluster. Exclusively for the cognitively intact cluster, a lower proportion of patients with arterial hypertension could be determined. There was no difference in education level (university entrance qualification) between all clusters considered (<italic>p</italic> = 0.491).</p>
<p>Further detailed analysis (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 3</xref>) revealed no relevant differences between clusters in other echocardiographic and laboratory parameters.</p>
</sec>
<sec>
<title>3.4. Brain imaging data and neurological biomarkers</title>
<p>In cerebral MRI, visually rated cerebral and periventricular, and white matter hyperintensities did not differ between groups (<xref ref-type="table" rid="T3">Table 3</xref>). Equally, the frequency of cerebral ischemia did not differ with respect to territorial, border zones, or lacunar infarcts of the medullary camp. Further evaluation revealed reduced total brain volume (<italic>p</italic> = 0.017) in the globally deficient cluster.</p>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Neurochemical and neuroradiological measures according to cognitive clusters.</p></caption> 
<table frame="box" rules="all">
<thead>
<tr style="background-color:&#x00023;919498;color:&#x00023;ffffff">
<th valign="top" align="left"><bold>Parameter</bold></th>
<th valign="top" align="left"><bold>All patients (<italic>n</italic> = 147)</bold></th>
<th valign="top" align="left"><bold>No deficits (<italic>n</italic> = 42)</bold></th>
<th valign="top" align="left"><bold>Attention deficits (<italic>n</italic> = 55)</bold></th>
<th valign="top" align="left"><bold>Global deficits (<italic>n</italic> = 50)</bold></th>
<th valign="top" align="left"><bold><italic>P</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>Neuronal biomarkers</bold></td>
</tr> <tr>
<td valign="top" align="left">Glial fibrillary acidic protein (pg/ml)</td>
<td valign="top" align="left">247 (164&#x02013;380)</td>
<td valign="top" align="left">226 (137&#x02013;396)</td>
<td valign="top" align="left">212 (155&#x02013;348)</td>
<td valign="top" align="left">307 (194&#x02013;398)</td>
<td valign="top" align="left"><bold>0.048</bold><sup><bold>3&#x0003E;2</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">Neurofilament light chain (pg/ml)</td>
<td valign="top" align="left">26.2 (17.0&#x02013;41.6)</td>
<td valign="top" align="left">22.5 (14.5&#x02013;35.3)</td>
<td valign="top" align="left">27.5 (15.2&#x02013;42.7)</td>
<td valign="top" align="left">28.5 (22.6&#x02013;40.7)</td>
<td valign="top" align="left">0.127</td>
</tr> <tr>
<td valign="top" align="left">Phosphorylated tau protein (pg/ml)</td>
<td valign="top" align="left">1.63 (1.08&#x02013;2.50)</td>
<td valign="top" align="left">1.69 (1.04&#x02013;2.36)</td>
<td valign="top" align="left">1.38 (0.98&#x02013;2.40)</td>
<td valign="top" align="left">1.74 (1.22&#x02013;3.01)</td>
<td valign="top" align="left">0.183</td>
</tr> <tr style="background-color:#e0e1e3">
<td valign="top" align="left" colspan="6"><bold>MRI parameters</bold></td>
</tr> <tr>
<td valign="top" align="left">Lacunar infarction (%)</td>
<td valign="top" align="left">9 (6.7)</td>
<td valign="top" align="left">4 (9.7)</td>
<td valign="top" align="left">2 (3.8)</td>
<td valign="top" align="left">3 (6.3)</td>
<td valign="top" align="left">0.331</td>
</tr> <tr>
<td valign="top" align="left">Territorial infarction (%)</td>
<td valign="top" align="left">2 (1.4)</td>
<td valign="top" align="left">2 (5.1)</td>
<td valign="top" align="left">0 (0.0)</td>
<td valign="top" align="left">0 (0.0)</td>
<td valign="top" align="left">0.081</td>
</tr> <tr>
<td valign="top" align="left">Microinfarctions global (%)</td>
<td valign="top" align="left">(38)</td>
<td valign="top" align="left">17 (42)</td>
<td valign="top" align="left">22 (41)</td>
<td valign="top" align="left">16 (33)</td>
<td valign="top" align="left">0.810</td>
</tr> <tr>
<td valign="top" align="left">Total brain volume (ml)</td>
<td valign="top" align="left">1,184 (1,116&#x02013;1,251)</td>
<td valign="top" align="left">1,191 (1,135&#x02013;1,264)</td>
<td valign="top" align="left">1,198 (1,137&#x02013;1,269)</td>
<td valign="top" align="left">1,136 (1,100&#x02013;1,225)</td>
<td valign="top" align="left"><bold>0.017</bold><sup><bold>1&#x0003E;3</bold></sup></td>
</tr> <tr>
<td valign="top" align="left">White matter hyperintensity score (0&#x02013;3)</td>
<td valign="top" align="left">1 (1&#x02013;1)</td>
<td valign="top" align="left">1.00 (1.00)</td>
<td valign="top" align="left">1.00 (1.00)</td>
<td valign="top" align="left">1.00 (1.00)</td>
<td valign="top" align="left">0.232</td>
</tr> <tr>
<td valign="top" align="left">White matter hyperintensity volume (mm3)</td>
<td valign="top" align="left">2.66 (1.55&#x02013;4.70)</td>
<td valign="top" align="left">2.79 (1.40&#x02013;5.07)</td>
<td valign="top" align="left">2.48 (1.52&#x02013;3.84)</td>
<td valign="top" align="left">2.88 (4.99)</td>
<td valign="top" align="left">0.318</td>
</tr> <tr>
<td valign="top" align="left">Periventricular hyperintensity score (0&#x02013;3)</td>
<td valign="top" align="left">1.00 (1.00&#x02013;1.00)</td>
<td valign="top" align="left">1.00 (1.00)</td>
<td valign="top" align="left">1.00 (1.00)</td>
<td valign="top" align="left">1.00 (1.75)</td>
<td valign="top" align="left">0.818</td>
</tr> <tr>
<td valign="top" align="left">Outer cerebral atrophy score (0&#x02013;8)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;3.25)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;4.00)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;3.00)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;3.00)</td>
<td valign="top" align="left">0.778</td>
</tr> <tr>
<td valign="top" align="left">Inner cerebral atrophy score (0&#x02013;8)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;4.00)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;5.00)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;4.00)</td>
<td valign="top" align="left">3.00 (3.00&#x02013;4.00)</td>
<td valign="top" align="left">0.835</td>
</tr> <tr>
<td valign="top" align="left">Cerebral atrophy score total (0&#x02013;8)</td>
<td valign="top" align="left">3.00 (2.50&#x02013;4.00)</td>
<td valign="top" align="left">3.00 (2.00&#x02013;4.75)</td>
<td valign="top" align="left">3.00 (2.25&#x02013;4.00)</td>
<td valign="top" align="left">3.00 (2.50&#x02013;3.50)</td>
<td valign="top" align="left">0.820</td>
</tr> <tr>
<td valign="top" align="left">Hippocampal atrophy right (0&#x02013;4)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;3.00)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;2.00)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;2.00)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;3.00)</td>
<td valign="top" align="left">0.233</td>
</tr> <tr>
<td valign="top" align="left">Hippocampal atrophy left (0&#x02013;4)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;3.00)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;3.00)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;3.00)</td>
<td valign="top" align="left">2.50 (2.00&#x02013;3.00)</td>
<td valign="top" align="left">0.221</td>
</tr> <tr>
<td valign="top" align="left">Hippocampal atrophy total (0&#x02013;4)</td>
<td valign="top" align="left">2.00 (1.38&#x02013;2.63)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;2.50)</td>
<td valign="top" align="left">2.00 (1.00&#x02013;2.50)</td>
<td valign="top" align="left">2.00 (1.50&#x02013;3.00)</td>
<td valign="top" align="left">0.179</td>
</tr> <tr>
<td valign="top" align="left">Pathological Scheltens&#x00027; score</td>
<td valign="top" align="left">106 (74.6)</td>
<td valign="top" align="left">28 (68.3)</td>
<td valign="top" align="left">37 (69.8)</td>
<td valign="top" align="left">41 (85.4)</td>
<td valign="top" align="left">0.107</td>
</tr></tbody>
</table>
<table-wrap-foot>
<p>Count (percentage) and median (interquartile range) are shown. Significant differences in <italic>post hoc</italic> analyses are indicated by greater than (&#x0003E;) and less than (&#x0003C;) sign. Bold numbers indicate values equal to or below a significance level of <italic>p</italic> = 0.05.</p>
</table-wrap-foot>
</table-wrap>
<p>In the analysis of serum biomarkers for central nervous system damage (<xref ref-type="table" rid="T3">Table 3</xref>), serum GFAP concentrations were elevated in the globally deficient cluster (347 &#x000B1; 231 pg/ml) compared with the other clusters (<italic>p</italic> = 0.048). NfL and pTau did not differ within the groups.</p>
</sec>
</sec>
<sec id="s4">
<title>4. Discussion</title>
<p>The current analysis is based on 147 chronic HF patients in the Cognition.Matters-HF study. The incidence of CI in HF patients in at least one domain was 59.9% in this cohort, which is broadly in line with several other publications (Dardiotis et al., <xref ref-type="bibr" rid="B9">2012</xref>). Several key findings emerged: We identified three distinct cognitive clusters with none, global, and only intensity of attention deficits. Clinical differences were marginal between clusters, with differences in women share, previous heart valve surgery, and hypertension. Global cognitive deficit associated with higher serum GFAP and global brain atrophy.</p>
<sec>
<title>4.1. Cognitive clusters in chronic HF</title>
<p>As a principal finding, we propose a division into cognitively intact, the intensity of attention, and globally deficient HF patients in a three-cluster solution. These findings partly contrast a publication from 2012, which suggested the three clusters &#x0201C;cognitively normal,&#x0201D; &#x0201C;memory deficient,&#x0201D; and &#x0201C;globally deficient&#x0201D; (Miller et al., <xref ref-type="bibr" rid="B18">2012</xref>). While patients with intact cognition and only intensity of attention deficits showed hardly any clinical differences, patients with global deficits were more likely to be female, have had more heart valve surgery, and tended to have lower brain volumes. Elevated serum GFAP in this cluster parallels these findings.</p>
</sec>
<sec>
<title>4.2. Intensity of attention deficits</title>
<p>Attention deficit itself is a known consequence of chronic HF (Alosco et al., <xref ref-type="bibr" rid="B4">2012b</xref>). The here-described selective intensity of attention deficits in a relevant proportion of patients suggests that this area behaves independently of others. The cross-sectional approach of this analysis limits further interpretation. It would be interesting to investigate whether the intensity of attention deficits may be early signs of global CI or represent a completely independent signature of CI. However, it has been shown that clinical treatment can reverse the intensity of attention deficits in chronic HF (Almeida and Tamai, <xref ref-type="bibr" rid="B2">2001</xref>), suggesting unstable, fluid performance in this domain. Based on this, it is debatable whether attention is such an unstable measure that it may not be ideally suited to adequately assess global cognition deficits in HF patients over the long term.</p>
</sec>
<sec>
<title>4.3. Clinical characteristics of generated clusters</title>
<p>Surprisingly, none of the parameters clinically associated with HF differed between clusters. This is in marked contrast to many other publications where left ventricular ejection fraction, NT-proBNP, NYHA class, and 6-min walking distance were significantly associated with CI (Zuccal&#x000E0; et al., <xref ref-type="bibr" rid="B36">1997</xref>; Cacciatore et al., <xref ref-type="bibr" rid="B7">1998</xref>; Pullicino and Hart, <xref ref-type="bibr" rid="B23">2001</xref>; Baldasseroni et al., <xref ref-type="bibr" rid="B5">2010</xref>; van Vliet et al., <xref ref-type="bibr" rid="B30">2014</xref>). A possible explanation might be that other studies did not combine different cognitive domains into clusters, but analyzed performance in the respective domains directly. Therefore, clinical differences between patients with or without deficits in one domain might disappear after individual clustering.</p>
<p>The overrepresentation of women in the global deficit cluster is consistent with recent literature confirming the role of the female gender as a possible independent risk factor CI in HF patients (Volgman et al., <xref ref-type="bibr" rid="B32">2019</xref>; Rossi et al., <xref ref-type="bibr" rid="B25">2022</xref>). These differences are described as multifactorial, consisting of a stronger inflammatory reaction, higher reactivity of the autonomic system, and the amygdala as well as more frequent microvascular complaints or lack of cerebral perfusion (Volgman et al., <xref ref-type="bibr" rid="B32">2019</xref>). Nevertheless, interpretations of gender differences must be made with caution, as the proportion of female patients of approximately 16% is strongly underrepresented in our cohort.</p>
<p>When considering cardiovascular risk factors (hypertension, diabetes mellitus, smoking, hyperlipidemia, and family history), the only differences were found in diabetes mellitus (higher proportion of women, <italic>p</italic> = 0.033). The genders did not differ in the number of interventions, the cause of heart failure (ischemic vs. non-ischemic), the frequency of stroke, or other comorbidities, such as chronic obstructive pulmonary disease, peripheral artery disease, and malignancies.</p>
<p>A gender-specific difference in HF patients is very present and absolutely plausible as published previously. The pathophysiological aspects and disease-specific entities appear to be fundamentally different. While women tend to develop microvascular dysfunction associated with HFpEF or conditions, such as Takotsubo or radiotherapy-associated cardiomyopathies, men are more likely to present with macrovascular conditions, which are more likely to manifest in myocardial infarction or coronary artery disease and may have a substantially different impact on cognition. Indeed, women with HF seem to suffer more severe impairment in cognition compared with men, which might have had a significant impact on cluster allocation with higher women share in the global deficits cluster (Lam et al., <xref ref-type="bibr" rid="B16">2019</xref>; Volgman et al., <xref ref-type="bibr" rid="B32">2019</xref>).</p>
<p>High frequencies of patients with valve operations in the &#x0201C;globally deficient&#x0201D; cluster may relate to described CI after aortic valve replacement (Zimpfer et al., <xref ref-type="bibr" rid="B35">2002</xref>) and mitral valve replacement (Zhang et al., <xref ref-type="bibr" rid="B34">2011</xref>). In these conditions, brain lesions were identified in the temporal lobe, a region also affected by chronic HF (Bokeriia et al., <xref ref-type="bibr" rid="B6">2005</xref>; Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). Our results are in contrast to some publications, which have found subcortical ischemia after heart valve surgery, but no reversible changes in cognition over a period of 4 months (Knipp et al., <xref ref-type="bibr" rid="B15">2005</xref>), while we could not find correlates for valve surgery in brain morphological changes. In general, cognition is expected to change with aspects such as cardiopulmonary bypass time and possibly the etiology of valvular pathologies, which need further examination in patients with HF (Greaves et al., <xref ref-type="bibr" rid="B13">2020</xref>). Further differentiation of valve defects certainly offers opportunities for more precise comparisons in future studies. However, in our cohort, the number of aortic valve stenosis (<italic>p</italic> = 0.705) did not differ while there was a higher proportion of mitral valve insufficiencies in the global deficient cluster (<italic>p</italic> = 0.015) when examined separately.</p>
<p>Hypertensive patients were highly represented in both our &#x0201C;intensity of attention&#x0201D; and the &#x0201C;globally deficient&#x0201D; cluster. CI is a well-known phenomenon associated with hypertension (Mercado and Hilsabeck, <xref ref-type="bibr" rid="B17">2005</xref>; Reitz et al., <xref ref-type="bibr" rid="B24">2007</xref>). Indeed, hypertension was also independently associated with the intensity of attention/executive function/psychomotor speed in another cohort of HF patients (Alosco et al., <xref ref-type="bibr" rid="B3">2012a</xref>). Thus, controlled blood pressure might serve as a protective factor in our &#x0201C;non-deficient&#x0201D; cluster cohort. As an explanation, pathophysiological properties, such as neuroinflammation, disturbances of the blood&#x02013;brain barrier, and chronical low perfusion, may be causative factors (Ungvari et al., <xref ref-type="bibr" rid="B29">2021</xref>).</p>
<p>In fact, the selective influence of atrial fibrillation on cluster assignment and the prevalence of cognitive deficits within the clusters should be questioned, as the results are only very borderline significant and the clusters of no deficits and attention deficits are clinically very similar. In addition, our previous work has shown that although atrial fibrillation is a risk factor for cognitive impairment in general, it exists independently from HF-specific cognitive impairment (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>).</p>
</sec>
<sec>
<title>4.4. Neurochemical and neuroradiological differences</title>
<p>Slightly higher serum levels of GFAP were seen in our &#x0201C;global deficient&#x0201D; cluster. Previous publications have already shown that GFAP is associated with CI (especially memory function) not only in Alzheimer&#x00027;s disease but also in chronic HF (Cicognola et al., <xref ref-type="bibr" rid="B8">2021</xref>; Traub et al., <xref ref-type="bibr" rid="B28">2022</xref>). In this line, neuronal biomarkers such as GFAP might be better suitable for predicting CI in HF patients compared with established HF measures. Moreover, we found slight differences in global brain volumes between cognitive clusters with the lowest volumes in the globally deficient cluster in a subset of patients, which is in line with our previously published finding in cognitively impaired HF patients (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). Furthermore, it was shown previously that lower brain volume influences both executive functions and memory (Fine et al., <xref ref-type="bibr" rid="B11">2001</xref>; Duarte et al., <xref ref-type="bibr" rid="B10">2006</xref>). It must be noted, that as total brain volume was not normalized to intracranial volume, reduced total brain volume in the &#x0201C;global deficits&#x0201D; group could reflect the fact that there were a higher proportion of females in this group.</p>
<p>Structural changes associated with cognitive decline in cardiac-compromised patients have been well-documented. One hypothesis is that differences in brain structure exist in principle compared with a normal cohort as found by us when comparing the whole HF cohort with a healthy cohort from the ASPS-Fam study from Graz, but not within the clusters when different clusters of HF patients are generated (Frey et al., <xref ref-type="bibr" rid="B12">2018</xref>). Within our long-term observation, both cognition and morphological aspects of the brain remained stable over time, generating our hypothesis that there are certain risk factors that affect cerebral morphology and cognition at the onset or even before the clinical manifestation of heart failure but do not necessarily cause progression. Thus, we see the results of the cluster analysis as confirmatory and believe that we have been able to objectify certain risk factors for cognitive impairment. In the end, the amazing compensatory mechanisms of the brain are probably responsible for the fact that even patients with different cerebral morphology alterations can have equal cognitive performance.</p>
</sec>
<sec>
<title>4.5. Strengths and limitations</title>
<p>Our study comprised extensive neuropsychological workup, laboratory measurements, and MRI data, which are clear strengths of this investigation. The cluster method provides a more complete and holistic picture of the cognitively impaired patient compared with other studies that often only consider individual correlations of separate cognitive domains. Nevertheless, our cross-sectional evaluation remains limiting in regard to predicting the development of cognitive function over time. Due to the cross-sectional approach and the small differences found, the findings might be not clear enough to derive general recommendations but to define further research needs. Furthermore, the lack of a control group appears to be limiting, as the influence of confounding variables could not be comprehensively controlled. To some extent, the cognitively intact cluster can be seen as a reference group against the deficient ones in order to draw conclusions about the extent of certain differences. As the analysis used here was considered exploratory, no additional correction for multiple testing was performed. Thus, it must be taken into account that the inclusion of many variables may have led to false-positive results. Our results suggest that single HF parameters may not be sufficient to serve as a screening tool for CI in HF on their own. The solution could be in combining several markers covering more facets of HF, which needs further investigation.</p>
</sec>
</sec>
<sec id="s5">
<title>5. Conclusion</title>
<p>Cluster analysis of patients with chronic HF revealed individual cognitive profiles with only marginal clinical, cardiological, and neuroradiological differences. It was interesting to see that selective deficits in the cognitive domain intensity of attention defined a separate cognitive cluster. Larger studies with a longitudinal analysis will be needed to identify the time-stability of cluster affiliation. Furthermore, the role of neuronal biomarkers and brain MRI awaits further evaluation. Associations between neuropsychological dimensions and their influencing factors may allow a better understanding of CI profiles and possible approaches to prevention in HF patients.</p>
</sec>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Ethics Committee of the University Hospital W&#x000FC;rzburg. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>MP, SF, SS, GS, and AF: conceptualization. RS, GH, and MP: methodology. JT, DG, GH, MP, SS, and AF: formal analysis. RS, MV, GH, MP, and GS: resources. JT and DG: writing&#x02014;original draft preparation. RS, GH, MP, SF, SS, GS, and AF: writing&#x02014;review and editing. JT: visualization. SS, GS, and AF: supervision. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>This work received public funding from the BMBF (Bundesministerium f&#x000FC;r Bildung und Forschung; 01ES0816, 01ES01901, and 01ES01902; Comprehensive Heart Failure Center: 01EO1004), habilitation grant (AF), and UNION-CVD Clinician Scientist Program grant (JT) by the Interdisciplinary Center of Clinical Research W&#x000FC;rzburg (DFG project number: 413657723). SF and AF received funding from the German Research Foundation (DFG project numbers: 391580509 and 453989101).</p>
</sec>
<ack><p>We thank the multidisciplinary study team for their excellent support.</p>
</ack>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnhum.2023.1126553/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnhum.2023.1126553/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname> <given-names>O. P.</given-names></name> <name><surname>Garrido</surname> <given-names>G. J.</given-names></name> <name><surname>Beer</surname> <given-names>C.</given-names></name> <name><surname>Lautenschlager</surname> <given-names>N. T.</given-names></name> <name><surname>Arnolda</surname> <given-names>L.</given-names></name> <name><surname>Flicker</surname> <given-names>L.</given-names></name></person-group> (<year>2012</year>). <article-title>Cognitive and brain changes associated with ischaemic heart disease and heart failure</article-title>. <source>Eur. Heart J</source>. <volume>33</volume>, <fpage>1769</fpage>&#x02013;<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehr467</pub-id><pub-id pub-id-type="pmid">22296945</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname> <given-names>O. P.</given-names></name> <name><surname>Tamai</surname> <given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Clinical treatment reverses attentional deficits in congestive heart failure</article-title>. <source>BMC Geriatr</source>. <volume>1</volume>, <fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2318-1-2</pub-id><pub-id pub-id-type="pmid">11604103</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alosco</surname> <given-names>M. L.</given-names></name> <name><surname>Brickman</surname> <given-names>A. M.</given-names></name> <name><surname>Spitznagel</surname> <given-names>M. B.</given-names></name> <name><surname>van Dulmen</surname> <given-names>M.</given-names></name> <name><surname>Raz</surname> <given-names>N.</given-names></name> <name><surname>Cohen</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2012a</year>). <article-title>The independent association of hypertension with cognitive function among older adults with heart failure</article-title>. <source>J. Neurol. Sci</source>. <volume>323</volume>, <fpage>216</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2012.09.019</pub-id><pub-id pub-id-type="pmid">23026535</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alosco</surname> <given-names>M. L.</given-names></name> <name><surname>Spitznagel</surname> <given-names>M. B.</given-names></name> <name><surname>van Dulmen</surname> <given-names>M.</given-names></name> <name><surname>Raz</surname> <given-names>N.</given-names></name> <name><surname>Cohen</surname> <given-names>R.</given-names></name> <name><surname>Sweet</surname> <given-names>L. H.</given-names></name> <etal/></person-group>. (<year>2012b</year>). <article-title>Cognitive function and treatment adherence in older adults with heart failure</article-title>. <source>Psychosom. Med</source>. <volume>74</volume>, <fpage>965</fpage>&#x02013;<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1097/PSY.0b013e318272ef2a</pub-id><pub-id pub-id-type="pmid">23115344</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldasseroni</surname> <given-names>S.</given-names></name> <name><surname>Mossello</surname> <given-names>E.</given-names></name> <name><surname>Romboli</surname> <given-names>B.</given-names></name> <name><surname>Orso</surname> <given-names>F.</given-names></name> <name><surname>Colombi</surname> <given-names>C.</given-names></name> <name><surname>Fumagalli</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Relationship between cognitive function and 6-minute walking test in older outpatients with chronic heart failure</article-title>. <source>Aging Clin. Exp. Res</source>. <volume>22</volume>, <fpage>308</fpage>&#x02013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1007/BF03324936</pub-id><pub-id pub-id-type="pmid">21116123</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bokeriia</surname> <given-names>L. A.</given-names></name> <name><surname>Golukhova</surname> <given-names>E. Z.</given-names></name> <name><surname>Polunina</surname> <given-names>A. G.</given-names></name> <name><surname>Davydov</surname> <given-names>D. M.</given-names></name> <name><surname>Begachev</surname> <given-names>A. V.</given-names></name></person-group> (<year>2005</year>). <article-title>Neural correlates of cognitive dysfunction after cardiac surgery</article-title>. <source>Brain Res. Rev</source>. <volume>50</volume>, <fpage>266</fpage>&#x02013;<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2005.08.001</pub-id><pub-id pub-id-type="pmid">16198423</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cacciatore</surname> <given-names>F.</given-names></name> <name><surname>Abete</surname> <given-names>P.</given-names></name> <name><surname>Ferrara</surname> <given-names>N.</given-names></name> <name><surname>Calabrese</surname> <given-names>C.</given-names></name> <name><surname>Napoli</surname> <given-names>C.</given-names></name> <name><surname>Maggi</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Congestive heart failure and cognitive impairment in an older population</article-title>. <source>J. Am. Geriatr. Soc.</source> <volume>46</volume>, <fpage>1343</fpage>&#x02013;<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1111/j.1532-5415.1998.tb05999.x</pub-id><pub-id pub-id-type="pmid">9809754</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cicognola</surname> <given-names>C.</given-names></name> <name><surname>Janelidze</surname> <given-names>S.</given-names></name> <name><surname>Hertze</surname> <given-names>J.</given-names></name> <name><surname>Zetterberg</surname> <given-names>H.</given-names></name> <name><surname>Blennow</surname> <given-names>K.</given-names></name> <name><surname>Mattsson-Carlgren</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment</article-title>. <source>Alzheimers Res. Therapy</source> <volume>13</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s13195-021-00804-9</pub-id><pub-id pub-id-type="pmid">33773595</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dardiotis</surname> <given-names>E.</given-names></name> <name><surname>Giamouzis</surname> <given-names>G.</given-names></name> <name><surname>Mastrogiannis</surname> <given-names>D.</given-names></name> <name><surname>Vogiatzi</surname> <given-names>C.</given-names></name> <name><surname>Skoularigis</surname> <given-names>J.</given-names></name> <name><surname>Triposkiadis</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Cognitive impairment in heart failure</article-title>. <source>Cardiol. Res. Pract</source>. 2012, 595821. <pub-id pub-id-type="doi">10.1155/2012/595821</pub-id><pub-id pub-id-type="pmid">22720185</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname> <given-names>A.</given-names></name> <name><surname>Hayasaka</surname> <given-names>S.</given-names></name> <name><surname>Du</surname> <given-names>A.</given-names></name> <name><surname>Schuff</surname> <given-names>N.</given-names></name> <name><surname>Jahng</surname> <given-names>G.-H.</given-names></name> <name><surname>Kramer</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer&#x00027;s disease</article-title>. <source>Neurosci. Lett</source>. <volume>406</volume>, <fpage>60</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.07.029</pub-id><pub-id pub-id-type="pmid">16904823</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fine</surname> <given-names>C.</given-names></name> <name><surname>Lumsden</surname> <given-names>J.</given-names></name> <name><surname>Blair</surname> <given-names>R. J. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Dissociation between &#x00027;theory of mind&#x00027; and executive functions in a patient with early left amygdala damage</article-title>. <source>Brain</source> <volume>124</volume>, <fpage>287</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1093/brain/124.2.287</pub-id><pub-id pub-id-type="pmid">11157556</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname> <given-names>A.</given-names></name> <name><surname>Sell</surname> <given-names>R.</given-names></name> <name><surname>Homola</surname> <given-names>G. A.</given-names></name> <name><surname>Malsch</surname> <given-names>C.</given-names></name> <name><surname>Kraft</surname> <given-names>P.</given-names></name> <name><surname>Gunreben</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Cognitive deficits and related brain lesions in patients with chronic heart failure</article-title>. <source>JACC Heart Fail</source>. <volume>6</volume>, <fpage>583</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchf.2018.03.010</pub-id><pub-id pub-id-type="pmid">29885954</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greaves</surname> <given-names>D.</given-names></name> <name><surname>Psaltis</surname> <given-names>P. J.</given-names></name> <name><surname>Davis</surname> <given-names>D. H. J.</given-names></name> <name><surname>Ross</surname> <given-names>T. J.</given-names></name> <name><surname>Ghezzi</surname> <given-names>E. S.</given-names></name> <name><surname>Lampit</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Risk factors for delirium and cognitive decline following coronary artery bypass grafting surgery: a systematic review and meta-analysis</article-title>. <source>J. Am. Heart Assoc</source>. <volume>9</volume>, e<fpage>017275</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.120.017275</pub-id><pub-id pub-id-type="pmid">33164631</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname> <given-names>L.</given-names></name> <name><surname>Jorgensen</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Clustering mixed data</article-title>. <source>WIREs Data Mining Knowledge Discov</source>. <volume>1</volume>, <fpage>352</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1002/widm.33</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knipp</surname> <given-names>S. C.</given-names></name> <name><surname>Matatko</surname> <given-names>N.</given-names></name> <name><surname>Schlamann</surname> <given-names>M.</given-names></name> <name><surname>Wilhelm</surname> <given-names>H.</given-names></name> <name><surname>Thielmann</surname> <given-names>M.</given-names></name> <name><surname>Forsting</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function</article-title>. <source>Eur. J. Cardiothorac. Surg</source>. <volume>28</volume>, <fpage>88</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejcts.2005.02.043</pub-id><pub-id pub-id-type="pmid">15922616</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>C. S. P.</given-names></name> <name><surname>Arnott</surname> <given-names>C.</given-names></name> <name><surname>Beale</surname> <given-names>A. L.</given-names></name> <name><surname>Chandramouli</surname> <given-names>C.</given-names></name> <name><surname>Hilfiker-Kleiner</surname> <given-names>D.</given-names></name> <name><surname>Kaye</surname> <given-names>D. M.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Sex differences in heart failure</article-title>. <source>Eur. Heart J</source>. <volume>40</volume>, <fpage>3859</fpage>&#x02013;<lpage>68c</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehz835</pub-id><pub-id pub-id-type="pmid">31800034</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mercado</surname> <given-names>J. M.</given-names></name> <name><surname>Hilsabeck</surname> <given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Untreated hypertension can lead to memory loss by cutting down on blood flow to the brain</article-title>. <source>Neurology</source> <volume>64</volume>, <fpage>E28</fpage>&#x02013;<lpage>E29</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.64.8.E28</pub-id><pub-id pub-id-type="pmid">15851715</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>L. A.</given-names></name> <name><surname>Spitznagel</surname> <given-names>M. B.</given-names></name> <name><surname>Alosco</surname> <given-names>M. L.</given-names></name> <name><surname>Cohen</surname> <given-names>R. A.</given-names></name> <name><surname>Raz</surname> <given-names>N.</given-names></name> <name><surname>Sweet</surname> <given-names>L. H.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Cognitive profiles in heart failure: a cluster analytic approach</article-title>. <source>J. Clin. Exp. Neuropsychol</source>. <volume>34</volume>, <fpage>509</fpage>&#x02013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1080/13803395.2012.663344</pub-id><pub-id pub-id-type="pmid">22375800</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okonkwo</surname> <given-names>O. C.</given-names></name> <name><surname>Alosco</surname> <given-names>M. L.</given-names></name> <name><surname>Jerskey</surname> <given-names>B. A.</given-names></name> <name><surname>Sweet</surname> <given-names>L. H.</given-names></name> <name><surname>Ott</surname> <given-names>B. R.</given-names></name> <name><surname>Tremont</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment</article-title>. <source>Alzheimers Dement</source>. <volume>6</volume>, <fpage>404</fpage>&#x02013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2010.02.003</pub-id><pub-id pub-id-type="pmid">20813341</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ponikowski</surname> <given-names>P.</given-names></name> <name><surname>Voors</surname> <given-names>A. A.</given-names></name> <name><surname>Anker</surname> <given-names>S. D.</given-names></name> <name><surname>Bueno</surname> <given-names>H.</given-names></name> <name><surname>Cleland</surname> <given-names>J. G. F.</given-names></name> <name><surname>Coats</surname> <given-names>A. J. S.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</article-title>. <source>Eur. Heart J</source>. <volume>37</volume>, <fpage>2129</fpage>&#x02013;<lpage>2200</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehw128</pub-id><pub-id pub-id-type="pmid">27207191</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Prasanna</surname> <given-names>K. S. L.</given-names></name> <name><surname>Vijaya</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>&#x0201C;Building an efficient heart disease prediction system by using clustering techniques,&#x0201D;</article-title> in <source>High Performance Computing and Networking. Lecture Notes in Electrical Engineering, Vol 85</source>3, eds C. Satyanarayana, D. Samanta, X. Z. Gao, and R. K. Kapoor (<publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>69</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-16-9885-9_6</pub-id><pub-id pub-id-type="pmid">35908307</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pressler</surname> <given-names>S. J.</given-names></name> <name><surname>Subramanian</surname> <given-names>U.</given-names></name> <name><surname>Perkins</surname> <given-names>S. M.</given-names></name> <name><surname>Gradus-Pizlo</surname> <given-names>I.</given-names></name> <name><surname>Kareken</surname> <given-names>D.</given-names></name> <name><surname>Kim</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Measuring depressive symptoms in heart failure: validity and reliability of the patient health questionnaire-8</article-title>. <source>Am. J. Crit. Care</source> <volume>20</volume>, <fpage>146</fpage>&#x02013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.4037/ajcc2010931</pub-id><pub-id pub-id-type="pmid">20378777</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pullicino</surname> <given-names>P. M.</given-names></name> <name><surname>Hart</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>Cognitive impairment in congestive heart failure? Embolism vs hypoperfusion</article-title>. <source>Neurology</source> <volume>57</volume>, <fpage>1945</fpage>&#x02013;<lpage>1946</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.57.11.1945</pub-id><pub-id pub-id-type="pmid">11739807</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reitz</surname> <given-names>C.</given-names></name> <name><surname>Tang</surname> <given-names>M.-X.</given-names></name> <name><surname>Manly</surname> <given-names>J.</given-names></name> <name><surname>Mayeux</surname> <given-names>R.</given-names></name> <name><surname>Luchsinger</surname> <given-names>J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Hypertension and the risk of mild cognitive impairment</article-title>. <source>Arch. Neurol</source>. <volume>64</volume>, <fpage>1734</fpage>&#x02013;<lpage>1740</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.12.1734</pub-id><pub-id pub-id-type="pmid">18071036</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>A.</given-names></name> <name><surname>Mikail</surname> <given-names>N.</given-names></name> <name><surname>Bengs</surname> <given-names>S.</given-names></name> <name><surname>Haider</surname> <given-names>A.</given-names></name> <name><surname>Treyer</surname> <given-names>V.</given-names></name> <name><surname>Buechel</surname> <given-names>R. R.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Heart-brain interactions in cardiac and brain diseases: why sex matters</article-title>. <source>Eur. Heart J</source>. <volume>43</volume>, <fpage>3971</fpage>&#x02013;<lpage>3980</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehac061</pub-id><pub-id pub-id-type="pmid">35194633</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sauve</surname> <given-names>M. J.</given-names></name> <name><surname>Lewis</surname> <given-names>W. R.</given-names></name> <name><surname>Blankenbiller</surname> <given-names>M.</given-names></name> <name><surname>Rickabaugh</surname> <given-names>B.</given-names></name> <name><surname>Pressler</surname> <given-names>S. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Cognitive impairments in chronic heart failure: a case controlled study</article-title>. <source>J. Card. Fail</source>. <volume>15</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardfail.2008.08.007</pub-id><pub-id pub-id-type="pmid">19181287</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Schellig</surname> <given-names>D.</given-names></name> <name><surname>Sch&#x000E4;chtele</surname> <given-names>B.</given-names></name></person-group> (<year>2009</year>). <source>VVM2 Visual and Verbal Memory Test, 2nd Edn</source>. <publisher-loc>Frankfurt am Main</publisher-loc>: <publisher-name>Swets Test Services</publisher-name>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Traub</surname> <given-names>J.</given-names></name> <name><surname>Otto</surname> <given-names>M.</given-names></name> <name><surname>Sell</surname> <given-names>R.</given-names></name> <name><surname>Homola</surname> <given-names>G. A.</given-names></name> <name><surname>Steinacker</surname> <given-names>P.</given-names></name> <name><surname>Oeckl</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure</article-title>. <source>ESC Heart Fail</source>. <volume>9</volume>, <fpage>2626</fpage>&#x02013;<lpage>2634</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.13986</pub-id><pub-id pub-id-type="pmid">35611842</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungvari</surname> <given-names>Z.</given-names></name> <name><surname>Toth</surname> <given-names>P.</given-names></name> <name><surname>Tarantini</surname> <given-names>S.</given-names></name> <name><surname>Prodan</surname> <given-names>C. I.</given-names></name> <name><surname>Sorond</surname> <given-names>F.</given-names></name> <name><surname>Merkely</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Hypertension-induced cognitive impairment: from pathophysiology to public health</article-title>. <source>Nat. Rev. Nephrol</source>. <volume>17</volume>, <fpage>639</fpage>&#x02013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-021-00430-6</pub-id><pub-id pub-id-type="pmid">34127835</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Vliet</surname> <given-names>P.</given-names></name> <name><surname>Sabayan</surname> <given-names>B.</given-names></name> <name><surname>Wijsman</surname> <given-names>L. W.</given-names></name> <name><surname>Poortvliet</surname> <given-names>R. K. E.</given-names></name> <name><surname>Mooijaart</surname> <given-names>S. P.</given-names></name> <name><surname>de Ruijter</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>NT-proBNP, blood pressure, and cognitive decline in the oldest old. The Leiden 85-plus study</article-title>. <source>Neurology</source> <volume>83</volume>, <fpage>1192</fpage>&#x02013;<lpage>1199</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000000820</pub-id><pub-id pub-id-type="pmid">25142900</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogels</surname> <given-names>R. L.</given-names></name> <name><surname>Oosterman</surname> <given-names>J. M.</given-names></name> <name><surname>van Harten</surname> <given-names>B.</given-names></name> <name><surname>Gouw</surname> <given-names>A. A.</given-names></name> <name><surname>Schroeder-Tanka</surname> <given-names>J. M.</given-names></name> <name><surname>Scheltens</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Neuroimaging and correlates of cognitive function among patients with heart failure</article-title>. <source>Dement. Geriatr. Cogn. Disord</source>. <volume>24</volume>, <fpage>418</fpage>&#x02013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1159/000109811</pub-id><pub-id pub-id-type="pmid">17938570</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Volgman</surname> <given-names>A. S.</given-names></name> <name><surname>Bairey Merz</surname> <given-names>C. N.</given-names></name> <name><surname>Aggarwal</surname> <given-names>N. T.</given-names></name> <name><surname>Bittner</surname> <given-names>V.</given-names></name> <name><surname>Bunch</surname> <given-names>T. J.</given-names></name> <name><surname>Gorelick</surname> <given-names>P. B.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Sex differences in cardiovascular disease and cognitive impairment: another health disparity for women?</article-title> <source>J. Am. Heart Assoc</source>. <volume>8</volume>, e<fpage>013154</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.119.013154</pub-id><pub-id pub-id-type="pmid">31549581</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname> <given-names>J. M.</given-names></name> <name><surname>Reinecke</surname> <given-names>A.</given-names></name> <name><surname>Brawn</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Why don&#x00027;t we see changes?: The role of attentional bottlenecks and limited visual memory</article-title>. <source>Vis. Cogn</source>. <volume>14</volume>, <fpage>749</fpage>&#x02013;<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1080/13506280500195292</pub-id><pub-id pub-id-type="pmid">18974792</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Ma</surname> <given-names>P.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Zhan</surname> <given-names>M.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Yao</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Preventive effect of gastrodin on cognitive decline after cardiac surgery with cardiopulmonary bypass: a double-blind, randomized controlled study</article-title>. <source>J. Huazhong Univ. Sci. Technol. Med. Sci</source>. <volume>31</volume>, <fpage>120</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s11596-011-0162-4</pub-id><pub-id pub-id-type="pmid">21336736</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimpfer</surname> <given-names>D.</given-names></name> <name><surname>Czerny</surname> <given-names>M.</given-names></name> <name><surname>Kilo</surname> <given-names>J.</given-names></name> <name><surname>Kasimir</surname> <given-names>M. T.</given-names></name> <name><surname>Madl</surname> <given-names>C.</given-names></name> <name><surname>Kramer</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Cognitive deficit after aortic valve replacement</article-title>. <source>Ann. Thorac. Surg</source>. <volume>74</volume>, <fpage>407</fpage>&#x02013;<lpage>412</lpage>; discussion: 12. <pub-id pub-id-type="doi">10.1016/S0003-4975(02)03651-2</pub-id><pub-id pub-id-type="pmid">12173821</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccal&#x000E0;</surname> <given-names>G.</given-names></name> <name><surname>Cattel</surname> <given-names>C.</given-names></name> <name><surname>Manes-Gravina</surname> <given-names>E.</given-names></name> <name><surname>Di Niro</surname> <given-names>M. G.</given-names></name> <name><surname>Cocchi</surname> <given-names>A.</given-names></name> <name><surname>Bernabei</surname> <given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>63</volume>, <fpage>509</fpage>&#x02013;<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.63.4.509</pub-id><pub-id pub-id-type="pmid">9343133</pub-id></citation></ref>
</ref-list> 
</back>
</article> 